IDYA compared with PRAX: revenue, margins and what each company keeps, and the suppliers and customers both name

IDYAIDEAYA Biosciences, Inc.

Mkt capRevenueRevenue

PRAXPraxis Precision Medicines, Inc.

Mkt capRevenueRevenue

Compare

IDYAIDEAYA Biosciences, Inc.

PRAXPraxis Precision Medicines, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

IDYA

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±13.6%▼−0.98%×0.07

Q2 FY26±6.7%▲+2.01%×0.30

Q1 FY26±7.8%▼−0.35%×0.04

Feb 17 '26±15.4%▲+1.62%×0.10

PRAX

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±9.4%▲+15.95%×1.69

Q1 FY26±7.4%▼−0.98%×0.14

= impliedIDYA realized, solidPRAX realized, hatchedOne scale, both sides: full bar = 16%× = |realized| ÷ impliedSource: market data

Feb 19 '26

±7.3%

▲+0.81%

×0.11

Q3 FY25±12.1%▼−4.14%×0.34

IDYAIDEAYA Biosciences, Inc.

31.24▲+1.91%· post 31.24

Mkt cap$3.0BRevenue$10MQ3 FY26Revenue—

PRAXPraxis Precision Medicines, Inc.

277.93▲+5.84%· post 281.99

ClosedNov 6 '26

Mkt cap$7.8BRevenue$7MQ4 FY24Revenue$9MFY24

Compare

ClosedNov 6 '26

IDYAIDEAYA Biosciences, Inc.

PRAXPraxis Precision Medicines, Inc.

31.24▲+1.91%post 31.24

Price

277.93▲+5.84%post 281.99

$3.0B

Mkt cap

$7.8B

Q3 FY26$10M

Revenue

$7MQ4 FY24

—

Revenue

$9MFY24

IDYA31.24▲+1.91%vsPRAX277.93▲+5.84%ClosedNov 6 '26